Literature DB >> 31594804

Preserving Kidney Function Instead of Replacing It.

Alan S Kliger1, Frank C Brosius2.   

Abstract

Entities:  

Keywords:  chronic dialysis; chronic kidney disease; diabetic nephropathy; economic impact; end stage kidney disease; epidemiology and outcomes; kidney function; nephrectomy; urinary tract physiological phenomena

Mesh：

Substances：

Year:  2019        PMID： 31594804      PMCID： PMC6946074          DOI： 10.2215/CJN.07820719

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  4 in total

1.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.

Authors:  Jason T Hurwitz; Amy J Grizzle; Jill Augustine; Rick Rehfeld; Ann Wild; Ivo Abraham
Journal:  J Manag Care Spec Pharm       Date:  2016-01

3.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Authors:  Radica Z Alicic; Michele T Rooney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

4.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245
  4 in total
  4 in total

1.  Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease.

Authors:  Katherine R Tuttle; Leslie Wong; Wendy St Peter; Glenda Roberts; Janani Rangaswami; Amy Mottl; Alan S Kliger; Raymond C Harris; Patrick O Gee; Kevin Fowler; David Cherney; Frank C Brosius; Christos Argyropoulos; Susan E Quaggin
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-01       Impact factor: 10.614

Review 2.  Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

Authors:  Luca De Nicola; Mario Cozzolino; Simonetta Genovesi; Loreto Gesualdo; Giuseppe Grandaliano; Roberto Pontremoli
Journal:  J Nephrol       Date:  2022-05-18       Impact factor: 4.393

Review 3.  Transforming the Care of Patients with Diabetic Kidney Disease.

Authors:  Frank C Brosius; David Cherney; Patrick O Gee; Raymond C Harris; Alan S Kliger; Katherine R Tuttle; Susan E Quaggin
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-08       Impact factor: 10.614

4.  Combined Albuminuria and Estimated GFR Laboratory Reporting Affects Primary Care Management of CKD.

Authors:  Joseph A Vassalotti; Sumeska Thavarajah
Journal:  Kidney Med       Date:  2020-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.